t
Piper Jaffray Raises Price Target on ISIS Pharmaceuticals (ISIS)
July 18th, 2012 - 0 comments - Filed Under - by Patrick Bannon
ISIS Pharmaceuticals, Inc. logoInvestment analysts at Piper Jaffray lifted their target price on shares of ISIS Pharmaceuticals (NASDAQ: ISIS) from $15.00 to $18.00 in a note issued to investors on Wednesday. The firm currently has an “overweight” rating on the stock.
The analysts wrote, “ISIS is the leading antisense company with a rich pipeline of drugs in development. The primary driver for ISIS shares remains KYNAMRO with European approval this year and a January 29, 2013 PDUFA date. While ISIS shares have risen considerably since May 1st, we look for continued upside driven by KYNAMRO approval, clinical data read-outs and new partnerships. ISIS remains a Top Pick for 2H:12.”
Shares of ISIS Pharmaceuticals traded up 1.67% during mid-day trading on Wednesday, hitting $13.97. ISIS Pharmaceuticals has a 52 week low of $6.25 and a 52 week high of $14.01. The company’s market cap is $1.400 billion.
ISIS Pharmaceuticals last issued its quarterly earnings data on Tuesday, May 8th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.04. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. On average, analysts predict that ISIS Pharmaceuticals will post $-0.79 earnings per share for the current fiscal year.
A number of other firms have also recently commented on ISIS. Analysts at Zacks reiterated a “neutral” rating on shares of ISIS Pharmaceuticals in a research note to investors on Tuesday, July 10th. They now have a $15.00 price target on the stock. Separately, analysts at Needham & Company initiated coverage on shares of ISIS Pharmaceuticals in a research note to investors on Tuesday, May 22nd. They set a “buy” rating and a $14.00 price target on the stock.
Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs.
- Forums
- ASX - By Stock
- PER
- isis flying.anp fueling up.
isis flying.anp fueling up.
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38503 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 194063 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.099 |
2 | 108491 | 0.098 |
1 | 30927 | 0.097 |
1 | 10004 | 0.096 |
3 | 162157 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 194063 | 5 |
0.110 | 254663 | 3 |
0.115 | 1334300 | 6 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |